E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 29.01% 27.44% 19.47% 15.29% 19.52%
Total Other Revenue -- -- -- -- --
Total Revenue 29.01% 27.44% 19.47% 15.29% 19.52%
Cost of Revenue 8.81% 96.38% 35.54% 36.65% 39.53%
Gross Profit 6.05% -314.39% -52.95% -58.29% -59.14%
SG&A Expenses 3.81% 3.31% 3.25% 8.29% 11.38%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 9.24% 5.53% -4.23% -2.59% -0.87%
Operating Income 5.84% 9.62% 18.42% 12.90% 12.28%
Income Before Tax 6.72% 11.62% 17.88% 13.77% 13.29%
Income Tax Expenses 187.51% -589.67% -128.68% -133.11% -132.04%
Earnings from Continuing Operations 6.17% 12.01% 18.82% 14.70% 14.25%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 6.17% 12.01% 18.82% 14.70% 14.25%
EBIT 5.84% 9.62% 18.42% 12.90% 12.28%
EBITDA 7.87% 12.10% 20.96% 14.87% 13.87%
EPS Basic 23.93% 28.01% 28.85% 21.74% 17.65%
Normalized Basic EPS 24.47% 27.39% 28.03% 19.24% 14.40%
EPS Diluted 23.87% 27.96% 28.80% 21.69% 17.65%
Normalized Diluted EPS 24.47% 27.39% 28.03% 19.24% 14.40%
Average Basic Shares Outstanding 23.12% 22.75% 14.98% 9.79% 5.15%
Average Diluted Shares Outstanding 23.12% 22.75% 14.98% 9.79% 5.15%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings